Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

WHO launches plan to jointly fight TB and HIV

22.01.2004


The World Health Organization (WHO) announced today a plan to expand collaboration between national tuberculosis and HIV/AIDS programmes to curb the growing pandemic of TB/HIV co-infection, with a principal focus on Africa where 70% of the world’s 14 million people who are co-infected live.



The new policy guidelines define activities necessary to address the dual epidemic of TB and HIV and gives clear guidance for countries on the circumstances under which these effective activities need to be carried out. It will give critical support for ‘3 by 5’, the WHO plan to provide antiretroviral (ARV) treatment to three million people living with AIDS by the end of 2005.

"TB/HIV is a deadly combination and needs to be tackled with an approach treating the whole person," said Dr. LEE Jong-wook, Director-General of the World Health Organization. "With effective treatment, TB can be cured, HIV managed, and the health of millions of people preserved."


A key element will be to rapidly expand voluntary HIV testing and counselling in TB programmes, with the aim of identifying and referring more than half a million TB patients who are HIV positive for ARV treatment in the next two years. With additional training for health workers, TB programmes will also assist in HIV prevention, ARV distribution and patient care.

At the same time, TB case-finding will be intensified in high HIV prevalence settings by introducing screening and testing for tuberculosis into HIV/AIDS service delivery points. In Africa, up to half of all people with HIV/AIDS develop TB, and up to 80% of tuberculosis patients are HIV infected.

By routinely screening and testing people with HIV/AIDS for TB, co-infected cases, without TB disease, can be treated with prophylactic drugs that prevent development of active tuberculosis, and cured if they already have it. This will prolong the lives of people with HIV/AIDS until they can benefit from the expanded availability of ARVs in the coming years.

UNAIDS Executive Director, Dr. Peter Piot, said: “TB is perhaps the greatest and most deadly opportunistic infection associated with AIDS. By tackling TB and HIV together, we can have a significant impact on improving the quality of life of people infected with HIV, while also controlling TB and preventing new infections.”

The vast majority of HIV-infected people do not know their HIV status and seek health care from general service providers. HIV testing and counselling for TB patients using rapid tests offers an entry point for a continuum of prevention, care, support and treatment for HIV/AIDS as well as for tuberculosis.

"Evidence has shown that the uptake of HIV testing by TB patients is high, so mainstreaming HIV testing and counselling into TB programmes will identify many more candidates for ARV treatment," said Dr. Mario Raviglione, the Director of WHO’s Stop TB Department. "We also know that ARVs reduce the development of TB in people with HIV, in some cases by up to 80%. So promoting and expanding a collaborative approach makes perfect sense."

The launch of the “Interim Policy on Collaborative TB/HIV Activities” guidelines coincides with the fourth round call for proposals by the Global Fund to Fight AIDS, TB and Malaria. The deadline for submissions is April 2004. The interim policy will enhance proposals which address the dual epidemic of TB and HIV. Already, the Global Fund has committed US$ 2.1 billion over two years to programmes in 120 countries.

Taken together, the two epidemics represent a massive challenge to public health. Forty million people are currently infected with HIV, and 5 million more are infected every year. According to WHO, one third of the world’s population is now infected with the TB bacillus, with more than 8 million people developing the active disease and 2 million dying of it each year.

Michael Luhan | WHO
Further information:
http://www.who.int

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Electrode materials from the microwave oven

19.10.2017 | Materials Sciences

New material for digital memories of the future

19.10.2017 | Materials Sciences

Physics boosts artificial intelligence methods

19.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>